Intravitreal Dexamethasone Implant (IDI) Alone and Combined with Navigated 577 nm Subthreshold Micropulse Laser (SML) for Diabetic Macular Oedema.

Lisa Toto Rossella D'AloisioAlberto QuartaDaniele LibertiniGiada D'OnofrioChiara De NicolaAnna RomanoRodolfo Mastropasqua

Published in: Journal of clinical medicine (2022)

the combined treatment showed good anatomical and functional outcomes for the treatment of DMO. In addition, IDI/SML seems to reduce injection frequency over time, improving patients' quality of life and reducing the socio-economic burden.

Keyphrases

newly diagnosed
ejection fraction
type diabetes
diabetic retinopathy
low dose
optical coherence tomography
prognostic factors
high dose
chronic kidney disease
combination therapy
high resolution
patient reported outcomes
wound healing